Healthcare Sector Stocks
The Healthcare sector has a total of 1066 stocks, with a combined market cap of $8.15 trillion, total revenue of $4.53 trillion and a weighted average PE ratio of 40.64.
Market Cap
8.15T
Revenue
4.53T
Profits
200.59B
PE Ratio
40.64
Profit Margin
4.43%
Dividend Yield
0.44%
1067 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 774.84B | -0.27% | 1,258,027 | 65.18B |
| 2 | JNJ | Johnson & Johnson | 546.75B | 0.79% | 3,809,815 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 348.92B | -0.06% | 2,833,251 | 61.16B |
| 4 | UNH | UnitedHealth Group Incorporated | 335.01B | 4.00% | 6,126,668 | 449.71B |
| 5 | AZN | AstraZeneca PLC | 293.62B | -0.77% | 1,682,110 | 58.74B |
| 6 | NVS | Novartis AG | 277.41B | -0.08% | 1,791,666 | 56.58B |
| 7 | MRK | Merck & Co., Inc. | 273.07B | 0.30% | 3,048,672 | 65.01B |
| 8 | NVO | Novo Nordisk A/S | 183.47B | 0.58% | 11,573,626 | 48.59B |
| 9 | AMGN | Amgen Inc. | 182.68B | -0.50% | 927,423 | 36.75B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 175.26B | 0.76% | 1,007,717 | 45.20B |
| 11 | ISRG | Intuitive Surgical, Inc. | 164.12B | -1.61% | 782,370 | 10.58B |
| 12 | ABT | Abbott Laboratories | 163.51B | 1.16% | 5,146,039 | 45.13B |
| 13 | GILD | Gilead Sciences, Inc. | 160.07B | 0.95% | 1,872,080 | 29.44B |
| 14 | PFE | Pfizer Inc. | 151.34B | -0.69% | 34,754,722 | 62.58B |
| 15 | DHR | Danaher Corporation | 126.74B | -0.86% | 1,925,470 | 24.78B |
| 16 | SYK | Stryker Corporation | 123.19B | -2.24% | 734,158 | 25.12B |
| 17 | BMY | Bristol-Myers Squibb Company | 118.65B | 0.57% | 2,706,093 | 48.19B |
| 18 | SNY | Sanofi | 111.77B | -0.02% | 1,146,784 | 54.60B |
| 19 | GSK | GSK plc | 109.04B | 0.31% | 3,634,954 | 43.97B |
| 20 | VRTX | Vertex Pharmaceuticals Incorporated | 109.00B | 0.59% | 326,104 | 12.00B |
| 21 | MDT | Medtronic plc | 105.10B | -1.28% | 3,338,964 | 35.48B |
| 22 | CVS | CVS Health Corporation | 103.89B | 3.45% | 3,787,135 | 399.83B |
| 23 | MCK | McKesson Corporation | 103.06B | 1.58% | 270,255 | 397.96B |
| 24 | HCA | HCA Healthcare, Inc. | 96.46B | -2.74% | 805,522 | 76.39B |
| 25 | BSX | Boston Scientific Corporation | 86.99B | -2.37% | 8,269,756 | 20.61B |
| 26 | ELV | Elevance Health, Inc. | 79.56B | 2.87% | 532,914 | 200.42B |
| 27 | CI | The Cigna Group | 75.42B | 1.23% | 980,514 | 274.90B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 75.01B | -0.97% | 216,075 | 14.34B |
| 29 | COR | Cencora, Inc. | 60.74B | 0.67% | 405,454 | 325.78B |
| 30 | MDLN | Medline Inc. | 58.85B | -0.95% | 1,678,249 | 28.43B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 52.36B | 0.28% | 1,448,187 | 28.48B |
| 32 | ZTS | Zoetis Inc. | 49.42B | -0.30% | 1,170,329 | 9.47B |
| 33 | ARGX | argenx SE | 49.41B | -1.82% | 110,316 | 4.24B |
| 34 | CAH | Cardinal Health, Inc. | 48.42B | 1.70% | 620,231 | 244.67B |
| 35 | EW | Edwards Lifesciences Corporation | 47.26B | -1.77% | 2,721,622 | 6.30B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 45.22B | -0.97% | 231,372 | 4.30B |
| 37 | BDX | Becton, Dickinson and Company | 42.38B | -0.93% | 1,005,625 | 21.92B |
| 38 | HLN | Haleon plc | 42.16B | 0.16% | 3,835,200 | 14.85B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 40.70B | -1.12% | 298,708 | 3.71B |
| 40 | ALC | Alcon Inc. | 36.74B | -1.33% | 693,700 | 10.40B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 36.61B | 0.58% | 4,319,758 | 17.26B |
| 42 | ONC | BeOne Medicines AG | 33.15B | 0.01% | 75,545 | 5.34B |
| 43 | A | Agilent Technologies, Inc. | 32.63B | -0.15% | 1,056,319 | 7.07B |
| 44 | RMD | ResMed Inc. | 31.47B | -2.26% | 614,321 | 5.40B |
| 45 | GEHC | GE HealthCare Technologies Inc. | 31.42B | -2.31% | 2,279,793 | 20.63B |
| 46 | RVMD | Revolution Medicines, Inc. | 30.58B | 10.43% | 3,811,233 | - |
| 47 | WAT | Waters Corporation | 29.52B | 0.31% | 536,423 | 3.17B |
| 48 | RPRX | Royalty Pharma plc | 29.46B | 0.08% | 1,209,528 | 2.38B |
| 49 | INSM | Insmed Incorporated | 28.84B | -1.75% | 650,292 | 606.42M |
| 50 | NTRA | Natera, Inc. | 28.53B | -1.51% | 1,087,221 | 2.31B |
| 51 | HUM | Humana Inc. | 27.95B | 4.10% | 1,360,670 | 129.66B |
| 52 | BIIB | Biogen Inc. | 26.90B | 1.46% | 411,460 | 9.89B |
| 53 | IQV | IQVIA Holdings Inc. | 26.85B | -2.39% | 638,260 | 16.31B |
| 54 | VEEV | Veeva Systems Inc. | 26.26B | 0.20% | 690,584 | 3.20B |
| 55 | PHG | Koninklijke Philips N.V. | 26.25B | -1.69% | 543,883 | 20.94B |
| 56 | MTD | Mettler-Toledo International Inc. | 25.59B | -0.85% | 37,296 | 4.03B |
| 57 | BNTX | BioNTech SE | 25.57B | -0.91% | 223,472 | 3.37B |
| 58 | UTHR | United Therapeutics Corporation | 24.79B | -0.24% | 103,934 | 3.18B |
| 59 | CNC | Centene Corporation | 24.40B | 14.07% | 10,536,080 | 179.48B |
| 60 | DXCM | DexCom, Inc. | 23.13B | -2.41% | 1,879,577 | 4.66B |
| 61 | DGX | Quest Diagnostics Incorporated | 21.64B | -0.58% | 242,033 | 11.28B |
| 62 | STE | STERIS plc | 21.48B | -1.44% | 225,098 | 5.83B |
| 63 | LH | Labcorp Holdings Inc. | 21.41B | -1.13% | 305,132 | 13.95B |
| 64 | WST | West Pharmaceutical Services, Inc. | 20.69B | -3.11% | 496,436 | 3.22B |
| 65 | ROIV | Roivant Sciences Ltd. | 19.90B | -0.14% | 2,398,284 | 13.31M |
| 66 | ILMN | Illumina, Inc. | 19.32B | -1.03% | 544,509 | 4.34B |
| 67 | INCY | Incyte Corporation | 18.80B | -1.29% | 1,208,530 | 5.36B |
| 68 | MRNA | Moderna, Inc. | 18.69B | -3.24% | 2,147,708 | 1.94B |
| 69 | VTRS | Viatris Inc. | 17.15B | -0.57% | 3,457,753 | 14.30B |
| 70 | SMMT | Summit Therapeutics Inc. | 16.64B | -3.07% | 1,440,063 | - |
| 71 | GMAB | Genmab A/S | 16.26B | 0.83% | 1,007,700 | 3.72B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 16.03B | -10.54% | 5,200,255 | 8.41B |
| 73 | THC | Tenet Healthcare Corporation | 15.77B | -2.96% | 421,757 | 21.31B |
| 74 | RGC | Regencell Bioscience Holdings Limited | 14.21B | -1.57% | 72,540 | - |
| 75 | ASND | Ascendis Pharma A/S | 13.68B | -2.30% | 1,501,102 | 845.52M |
| 76 | SNN | Smith & Nephew plc | 13.68B | -2.62% | 575,381 | 6.16B |
| 77 | BBIO | BridgeBio Pharma, Inc. | 13.59B | -5.92% | 9,405,151 | 502.08M |
| 78 | PEN | Penumbra, Inc. | 12.83B | -0.51% | 167,574 | 1.40B |
| 79 | NBIX | Neurocrine Biosciences, Inc. | 12.83B | -0.41% | 253,593 | 2.86B |
| 80 | PODD | Insulet Corporation | 12.74B | -2.30% | 372,675 | 2.71B |
| 81 | ALGN | Align Technology, Inc. | 12.67B | -4.21% | 790,682 | 4.03B |
| 82 | JAZZ | Jazz Pharmaceuticals plc | 12.42B | 0.24% | 230,136 | 4.27B |
| 83 | GMED | Globus Medical, Inc. | 12.38B | -2.61% | 268,574 | 2.94B |
| 84 | COO | The Cooper Companies, Inc. | 12.34B | -1.71% | 1,221,801 | 4.15B |
| 85 | FMS | Fresenius Medical Care AG | 12.25B | -0.11% | 236,027 | 23.05B |
| 86 | RDY | Dr. Reddy's Laboratories Limited | 11.99B | 0.32% | 1,258,071 | 3.85B |
| 87 | MEDP | Medpace Holdings, Inc. | 11.90B | -1.11% | 512,749 | 2.68B |
| 88 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.87B | -0.51% | 64,440 | 958.40M |
| 89 | IONS | Ionis Pharmaceuticals, Inc. | 11.80B | -1.12% | 827,384 | 943.71M |
| 90 | SOLV | Solventum Corporation | 11.78B | -2.68% | 319,901 | 8.33B |
| 91 | EXEL | Exelixis, Inc. | 11.42B | 0.67% | 873,287 | 2.32B |
| 92 | ELAN | Elanco Animal Health Incorporated | 11.14B | 0.97% | 1,647,873 | 4.72B |
| 93 | ENSG | The Ensign Group, Inc. | 11.03B | -0.62% | 128,075 | 5.06B |
| 94 | GH | Guardant Health, Inc. | 10.98B | -5.44% | 1,427,624 | 982.02M |
| 95 | BMRN | BioMarin Pharmaceutical Inc. | 10.35B | -0.51% | 297,445 | 3.22B |
| 96 | UHS | Universal Health Services, Inc. | 10.22B | -6.69% | 892,572 | 17.76B |
| 97 | EHC | Encompass Health Corporation | 10.11B | 0.72% | 302,317 | 5.94B |
| 98 | DVA | DaVita Inc. | 9.95B | 0.60% | 139,380 | 13.64B |
| 99 | MOH | Molina Healthcare, Inc. | 9.89B | 5.89% | 757,345 | 43.10B |
| 100 | BTSG | BrightSpring Health Services, Inc. | 9.84B | -1.14% | 994,500 | 12.91B |
| 101 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.80B | -4.89% | 791,867 | 1.09B |
| 102 | RVTY | Revvity, Inc. | 9.54B | -1.68% | 416,180 | 2.86B |
| 103 | BAX | Baxter International Inc. | 9.35B | -2.03% | 3,530,417 | 11.24B |
| 104 | AXSM | Axsome Therapeutics, Inc. | 9.34B | -2.56% | 326,953 | 638.50M |
| 105 | MASI | Masimo Corporation | 9.32B | -0.12% | 594,832 | 1.53B |
| 106 | TEM | Tempus AI, Inc. | 9.22B | -2.33% | 2,047,016 | 1.27B |
| 107 | PRAX | Praxis Precision Medicines, Inc. | 8.99B | -2.42% | 232,233 | 7.46M |
| 108 | ABVX | ABIVAX Société Anonyme | 8.98B | -0.88% | 310,395 | 5.37M |
| 109 | HSIC | Henry Schein, Inc. | 8.77B | -1.01% | 567,479 | 13.18B |
| 110 | PCVX | Vaxcyte, Inc. | 8.49B | -1.24% | 378,530 | - |
| 111 | TECH | Bio-Techne Corporation | 8.39B | -2.74% | 703,984 | 1.22B |
| 112 | CRL | Charles River Laboratories International, Inc. | 8.22B | -2.66% | 202,470 | 4.02B |
| 113 | NUVL | Nuvalent, Inc. | 8.02B | -1.95% | 156,665 | - |
| 114 | ATR | AptarGroup, Inc. | 7.96B | 0.05% | 111,334 | 3.78B |
| 115 | KRYS | Krystal Biotech, Inc. | 7.95B | -1.00% | 71,967 | 389.13M |
| 116 | ICLR | ICON Public Limited Company | 7.71B | -2.16% | 956,366 | 8.10B |
| 117 | CYTK | Cytokinetics, Incorporated | 7.69B | 0.42% | 987,982 | 88.04M |
| 118 | BIO | Bio-Rad Laboratories, Inc. | 7.58B | -2.19% | 160,878 | 2.58B |
| 119 | HALO | Halozyme Therapeutics, Inc. | 7.46B | -2.30% | 596,796 | 1.40B |
| 120 | IBRX | ImmunityBio, Inc. | 7.26B | -3.57% | 7,159,968 | 113.29M |
| 121 | QGEN | Qiagen N.V. | 7.03B | -10.70% | 4,950,684 | 2.09B |
| 122 | GKOS | Glaukos Corporation | 7.00B | -1.95% | 231,487 | 507.44M |
| 123 | HQY | HealthEquity, Inc. | 6.93B | -1.80% | 330,711 | 1.31B |
| 124 | KYMR | Kymera Therapeutics, Inc. | 6.89B | -2.61% | 193,222 | 39.21M |
| 125 | ACLX | Arcellx, Inc. | 6.75B | - | - | 22.29M |
| 126 | RGEN | Repligen Corporation | 6.61B | -0.92% | 373,925 | 738.26M |
| 127 | GRFS | Grifols, S.A. | 6.52B | -0.55% | 382,197 | 8.83B |
| 128 | HIMS | Hims & Hers Health, Inc. | 6.38B | -4.70% | 12,733,785 | 2.35B |
| 129 | APGE | Apogee Therapeutics, Inc. | 6.30B | -1.32% | 367,671 | - |
| 130 | PTGX | Protagonist Therapeutics, Inc. | 6.27B | -0.24% | 170,755 | 46.02M |
| 131 | BLTE | Belite Bio, Inc | 6.19B | -3.50% | 65,881 | - |
| 132 | TERN | Terns Pharmaceuticals, Inc. | 6.11B | 0.02% | 3,508,383 | - |
| 133 | CNTA | Centessa Pharmaceuticals plc | 6.10B | -0.13% | 661,291 | 15.00M |
| 134 | TFX | Teleflex Incorporated | 6.00B | 0.38% | 287,628 | 1.99B |
| 135 | SYRE | Spyre Therapeutics, Inc. | 6.00B | -3.28% | 337,866 | - |
| 136 | COGT | Cogent Biosciences, Inc. | 5.91B | 0.25% | 630,305 | - |
| 137 | CELC | Celcuity Inc. | 5.86B | -3.54% | 325,540 | - |
| 138 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.79B | -0.56% | 128,805 | 189.76M |
| 139 | MIRM | Mirum Pharmaceuticals, Inc. | 5.74B | 1.86% | 368,442 | 521.31M |
| 140 | CHE | Chemed Corporation | 5.69B | 0.35% | 233,470 | 2.54B |
| 141 | ALKS | Alkermes plc | 5.67B | 1.13% | 808,602 | 1.48B |
| 142 | BLCO | Bausch + Lomb Corporation | 5.61B | -0.88% | 186,159 | 5.10B |
| 143 | CGON | CG Oncology, Inc. | 5.55B | -1.69% | 210,399 | 4.04M |
| 144 | PTCT | PTC Therapeutics, Inc. | 5.53B | -3.73% | 837,548 | 1.73B |
| 145 | IMVT | Immunovant, Inc. | 5.50B | -5.56% | 1,100,067 | - |
| 146 | BRKR | Bruker Corporation | 5.50B | -1.07% | 435,586 | 3.44B |
| 147 | SRRK | Scholar Rock Holding Corporation | 5.46B | 2.59% | 484,660 | - |
| 148 | LNTH | Lantheus Holdings, Inc. | 5.38B | -1.55% | 505,985 | 1.54B |
| 149 | OSCR | Oscar Health, Inc. | 5.36B | 4.83% | 4,374,543 | 11.70B |
| 150 | AVTR | Avantor, Inc. | 5.35B | -0.63% | 2,428,973 | 6.55B |
| 151 | CAI | Caris Life Sciences, Inc. | 5.31B | -5.72% | 882,241 | 812.03M |
| 152 | PACS | PACS Group, Inc. | 5.27B | -4.96% | 767,489 | 5.29B |
| 153 | APLS | Apellis Pharmaceuticals, Inc. | 5.24B | -0.01% | 1,850,828 | 1.00B |
| 154 | TGTX | TG Therapeutics, Inc. | 5.18B | -0.76% | 804,363 | 616.29M |
| 155 | XENE | Xenon Pharmaceuticals Inc. | 5.11B | -1.38% | 339,630 | 7.50M |
| 156 | CRSP | CRISPR Therapeutics AG | 5.00B | 1.86% | 807,072 | 3.51M |
| 157 | CORT | Corcept Therapeutics Incorporated | 5.00B | 0.69% | 293,210 | 761.41M |
| 158 | WAY | Waystar Holding Corp. | 4.94B | 0.19% | 785,060 | 1.10B |
| 159 | LGND | Ligand Pharmaceuticals Incorporated | 4.65B | -4.12% | 85,953 | 268.09M |
| 160 | DOCS | Doximity, Inc. | 4.61B | 1.18% | 692,403 | 637.78M |
| 161 | DNTH | Dianthus Therapeutics, Inc. | 4.60B | -3.06% | 229,949 | 2.04M |
| 162 | FOLD | Amicus Therapeutics, Inc. | 4.55B | - | - | 634.21M |
| 163 | ALHC | Alignment Healthcare, Inc. | 4.47B | 4.34% | 2,134,935 | 3.95B |
| 164 | RDNT | RadNet, Inc. | 4.44B | -1.77% | 272,665 | 2.04B |
| 165 | STVN | Stevanato Group S.p.A. | 4.42B | - | 116,233 | 1.39B |
| 166 | SHC | Sotera Health Company | 4.41B | -2.15% | 892,625 | 1.16B |
| 167 | OPCH | Option Care Health, Inc. | 4.38B | -0.04% | 1,039,606 | 5.65B |
| 168 | NVST | Envista Holdings Corporation | 4.35B | -0.41% | 1,975,636 | 2.72B |
| 169 | LEGN | Legend Biotech Corporation | 4.34B | -0.89% | 1,289,365 | 1.03B |
| 170 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.06B | 21.19% | 2,152,777 | 677.56M |
| 171 | IRTC | iRhythm Holdings, Inc. | 4.06B | -1.21% | 176,223 | 747.14M |
| 172 | AMRX | Amneal Pharmaceuticals, Inc. | 4.02B | 0.16% | 488,331 | 3.02B |
| 173 | MMSI | Merit Medical Systems, Inc. | 3.97B | -1.23% | 299,303 | 1.52B |
| 174 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.94B | -2.51% | 994,378 | 7.70M |
| 175 | VKTX | Viking Therapeutics, Inc. | 3.83B | 0.23% | 883,007 | - |
| 176 | ACAD | ACADIA Pharmaceuticals Inc. | 3.82B | 0.40% | 566,232 | 1.07B |
| 177 | TVTX | Travere Therapeutics, Inc. | 3.80B | 0.76% | 512,489 | 490.73M |
| 178 | ORKA | Oruka Therapeutics, Inc. | 3.79B | -1.14% | 1,654,862 | - |
| 179 | TWST | Twist Bioscience Corporation | 3.67B | -1.85% | 249,845 | 391.56M |
| 180 | MANE | Veradermics, Incorporated | 3.66B | -2.08% | 581,132 | - |
| 181 | MMED | MiniMed Group, Inc. | 3.64B | 0.31% | 314,837 | 2.99B |
| 182 | TLX | Telix Pharmaceuticals Limited | 3.59B | 0.19% | 40,779 | 803.79M |
| 183 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.57B | -0.07% | 1,127,090 | 588.99M |
| 184 | BLLN | BillionToOne, Inc. | 3.56B | -5.21% | 224,265 | 305.11M |
| 185 | TNGX | Tango Therapeutics, Inc. | 3.55B | -6.46% | 1,678,793 | 62.38M |
| 186 | HNGE | Hinge Health, Inc. | 3.51B | 0.82% | 592,599 | 587.86M |
| 187 | TMDX | TransMedics Group, Inc. | 3.51B | -6.16% | 932,122 | 605.49M |
| 188 | OGN | Organon & Co. | 3.49B | 1.06% | 21,785,595 | 6.22B |
| 189 | BKD | Brookdale Senior Living Inc. | 3.33B | 0.47% | 964,291 | 3.05B |
| 190 | LIVN | LivaNova PLC | 3.32B | -4.32% | 337,937 | 1.39B |
| 191 | EWTX | Edgewise Therapeutics, Inc. | 3.28B | -0.29% | 1,261,097 | - |
| 192 | LQDA | Liquidia Corporation | 3.26B | -0.96% | 375,699 | 158.32M |
| 193 | NAMS | NewAmsterdam Pharma Company N.V. | 3.25B | -7.03% | 658,751 | 22.50M |
| 194 | DNLI | Denali Therapeutics Inc. | 3.17B | 0.15% | 511,668 | - |
| 195 | GPCR | Structure Therapeutics Inc. | 3.16B | -1.61% | 397,772 | - |
| 196 | PRVA | Privia Health Group, Inc. | 3.09B | 0.74% | 454,510 | 2.12B |
| 197 | RCUS | Arcus Biosciences, Inc. | 3.09B | -1.52% | 951,567 | 247.00M |
| 198 | ERAS | Erasca, Inc. | 3.09B | -48.15% | 39,138,179 | - |
| 199 | BEAM | Beam Therapeutics Inc. | 3.06B | 4.54% | 1,437,843 | 139.74M |
| 200 | ALMS | Alumis Inc. | 3.03B | -3.76% | 642,731 | 24.05M |
| 201 | ICUI | ICU Medical, Inc. | 3.00B | -2.45% | 109,941 | 2.23B |
| 202 | DYN | Dyne Therapeutics, Inc. | 2.99B | 0.44% | 943,167 | - |
| 203 | LFST | LifeStance Health Group, Inc. | 2.98B | 5.23% | 4,005,696 | 1.42B |
| 204 | CON | Concentra Group Holdings Parent, Inc. | 2.91B | -0.22% | 177,193 | 2.16B |
| 205 | KLRA | Kailera Therapeutics, Inc. | 2.90B | -0.23% | 145,136 | - |
| 206 | ITGR | Integer Holdings Corporation | 2.87B | -1.24% | 152,508 | 1.85B |
| 207 | ARQT | Arcutis Biotherapeutics, Inc. | 2.87B | -1.96% | 460,719 | 376.07M |
| 208 | NKTR | Nektar Therapeutics | 2.84B | -3.08% | 604,326 | 55.23M |
| 209 | WRBY | Warby Parker Inc. | 2.80B | -1.81% | 649,855 | 871.91M |
| 210 | SUPN | Supernus Pharmaceuticals, Inc. | 2.79B | -1.90% | 220,846 | 718.95M |
| 211 | HAE | Haemonetics Corporation | 2.78B | -1.06% | 209,273 | 1.32B |
| 212 | KOD | Kodiak Sciences Inc. | 2.78B | 2.02% | 234,373 | - |
| 213 | PBH | Prestige Consumer Healthcare Inc. | 2.77B | 0.38% | 142,943 | 1.10B |
| 214 | NHC | National HealthCare Corporation | 2.74B | -0.26% | 38,219 | 1.52B |
| 215 | TXG | 10x Genomics, Inc. | 2.74B | -3.64% | 979,705 | 642.82M |
| 216 | SLNO | Soleno Therapeutics, Inc. | 2.73B | 0.05% | 630,496 | 190.41M |
| 217 | VERA | Vera Therapeutics, Inc. | 2.69B | 0.54% | 867,373 | - |
| 218 | VCYT | Veracyte, Inc. | 2.65B | -1.39% | 226,359 | 517.15M |
| 219 | CLDX | Celldex Therapeutics, Inc. | 2.64B | -0.21% | 349,861 | 1.55M |
| 220 | IMNM | Immunome, Inc. | 2.63B | -0.89% | 220,748 | 6.94M |
| 221 | TARS | Tarsus Pharmaceuticals, Inc. | 2.62B | 1.17% | 237,073 | 451.36M |
| 222 | HTFL | HeartFlow, Inc. | 2.61B | -3.91% | 242,210 | 176.03M |
| 223 | ELVN | Enliven Therapeutics, Inc. | 2.60B | -3.23% | 272,154 | - |
| 224 | IRON | Disc Medicine, Inc. | 2.59B | -1.50% | 138,983 | - |
| 225 | LMAT | LeMaitre Vascular, Inc. | 2.56B | -2.10% | 59,406 | 249.60M |
| 226 | IDYA | IDEAYA Biosciences, Inc. | 2.56B | -1.26% | 299,323 | 218.71M |
| 227 | ACHC | Acadia Healthcare Company, Inc. | 2.55B | -1.56% | 900,824 | 3.31B |
| 228 | ADMA | ADMA Biologics, Inc. | 2.53B | -0.41% | 1,632,465 | 510.17M |
| 229 | RLAY | Relay Therapeutics, Inc. | 2.50B | -11.77% | 4,005,571 | 15.36M |
| 230 | ZLAB | Zai Lab Limited | 2.48B | 1.07% | 229,823 | 460.16M |
| 231 | RARE | Ultragenyx Pharmaceutical Inc. | 2.42B | 2.75% | 657,026 | 673.00M |
| 232 | GRDN | Guardian Pharmacy Services, Inc. | 2.38B | -1.03% | 118,170 | 1.45B |
| 233 | HCM | HUTCHMED (China) Limited | 2.35B | 0.26% | 18,649 | 548.51M |
| 234 | XRAY | DENTSPLY SIRONA Inc. | 2.34B | -2.09% | 1,837,748 | 3.68B |
| 235 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.21B | -0.90% | 1,165,915 | 874.84M |
| 236 | SRPT | Sarepta Therapeutics, Inc. | 2.21B | 0.29% | 1,186,489 | 2.20B |
| 237 | PAHC | Phibro Animal Health Corporation | 2.21B | -2.97% | 294,598 | 1.46B |
| 238 | AXGN | Axogen, Inc. | 2.18B | 6.60% | 1,797,768 | 238.11M |
| 239 | AAPG | Ascentage Pharma Group International | 2.16B | -1.58% | 3,172 | 82.08M |
| 240 | ADPT | Adaptive Biotechnologies Corporation | 2.15B | -1.55% | 659,063 | 276.98M |
| 241 | GRAL | GRAIL, Inc. | 2.15B | -4.56% | 201,507 | 147.17M |
| 242 | TYRA | Tyra Biosciences, Inc. | 2.12B | -3.36% | 272,505 | - |
| 243 | MLYS | Mineralys Therapeutics, Inc. | 2.12B | -4.63% | 608,594 | - |
| 244 | BHC | Bausch Health Companies Inc. | 2.11B | 1.34% | 1,792,176 | 10.27B |
| 245 | DFTX | Definium Therapeutics, Inc. | 2.10B | 0.19% | 626,768 | - |
| 246 | AUPH | Aurinia Pharmaceuticals Inc. | 2.09B | -1.53% | 421,994 | 283.06M |
| 247 | OMCL | Omnicell, Inc. | 2.08B | 21.53% | 1,336,619 | 1.23B |
| 248 | ZYME | Zymeworks Inc. | 2.07B | -1.51% | 158,709 | 105.97M |
| 249 | SEM | Select Medical Holdings Corporation | 2.05B | 0.24% | 646,421 | 5.45B |
| 250 | OCUL | Ocular Therapeutix, Inc. | 2.01B | -3.20% | 934,130 | 51.95M |
| 251 | MESO | Mesoblast Limited | 2.00B | -0.91% | 49,844 | 65.38M |
| 252 | NEOG | Neogen Corporation | 1.99B | -3.07% | 1,403,844 | 870.56M |
| 253 | STOK | Stoke Therapeutics, Inc. | 1.97B | -1.07% | 141,689 | 184.42M |
| 254 | CAPR | Capricor Therapeutics, Inc. | 1.97B | -3.13% | 354,024 | 11.13M |
| 255 | WGS | GeneDx Holdings Corp. | 1.96B | 1.09% | 163,632 | 427.54M |
| 256 | AHG | Akso Health Group | 1.91B | -3.46% | 166,641 | 14.84M |
| 257 | TRVI | Trevi Therapeutics, Inc. | 1.91B | -4.77% | 580,123 | - |
| 258 | ANAB | AnaptysBio, Inc. | 1.90B | -0.93% | 321,838 | 234.60M |
| 259 | ESTA | Establishment Labs Holdings Inc. | 1.89B | -1.62% | 110,176 | 211.08M |
| 260 | GLPG | Galapagos NV | 1.89B | -0.14% | 79,534 | 1.31B |
| 261 | MD | Pediatrix Medical Group, Inc. | 1.89B | -0.64% | 231,414 | 1.91B |
| 262 | INBX | Inhibrx Biosciences, Inc. | 1.88B | -2.31% | 221,915 | 1.30M |
| 263 | PHVS | Pharvaris N.V. | 1.86B | -0.80% | 93,165 | - |
| 264 | SNDX | Syndax Pharmaceuticals, Inc. | 1.85B | 0.10% | 357,099 | 172.35M |
| 265 | SGRY | Surgery Partners, Inc. | 1.85B | -0.55% | 366,477 | 3.31B |
| 266 | RXRX | Recursion Pharmaceuticals, Inc. | 1.82B | -0.86% | 4,996,470 | 74.68M |
| 267 | VCEL | Vericel Corporation | 1.81B | -3.58% | 249,977 | 276.26M |
| 268 | PVLA | Palvella Therapeutics, Inc. | 1.81B | -1.63% | 189,456 | - |
| 269 | AHCO | AdaptHealth Corp. | 1.80B | 1.45% | 326,220 | 3.24B |
| 270 | TSHA | Taysha Gene Therapies, Inc. | 1.80B | -2.94% | 966,767 | 9.77M |
| 271 | SION | Sionna Therapeutics, Inc. | 1.79B | 0.97% | 190,789 | - |
| 272 | ADUS | Addus HomeCare Corporation | 1.79B | 0.40% | 62,747 | 1.42B |
| 273 | ANIP | ANI Pharmaceuticals, Inc. | 1.79B | -1.34% | 99,720 | 883.37M |
| 274 | HRMY | Harmony Biosciences Holdings, Inc. | 1.78B | -0.71% | 246,539 | 868.45M |
| 275 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.78B | -4.44% | 455,173 | -665.00K |
| 276 | NRIX | Nurix Therapeutics, Inc. | 1.77B | 3.81% | 559,334 | 71.78M |
| 277 | ALMR | Alamar Biosciences, Inc. | 1.77B | -2.97% | 113,375 | 74.21M |
| 278 | AORT | Artivion, Inc. | 1.76B | -1.74% | 115,720 | 441.33M |
| 279 | SNDA | Sonida Senior Living, Inc. | 1.75B | 2.94% | 462,505 | 336.39M |
| 280 | INVA | Innoviva, Inc. | 1.74B | 0.86% | 250,585 | 411.33M |
| 281 | ASTH | Astrana Health, Inc. | 1.72B | 2.00% | 286,444 | 3.18B |
| 282 | VIR | Vir Biotechnology, Inc. | 1.65B | -4.04% | 837,642 | 68.56M |
| 283 | NBTX | Nanobiotix S.A. | 1.61B | -3.81% | 125,292 | 38.27M |
| 284 | RAPP | Rapport Therapeutics, Inc. | 1.61B | -4.94% | 105,054 | - |
| 285 | PRGO | Perrigo Company plc | 1.60B | 1.31% | 776,149 | 4.25B |
| 286 | INSP | Inspire Medical Systems, Inc. | 1.60B | 0.75% | 295,303 | 911.98M |
| 287 | GENB | Generate Biomedicines, Inc. | 1.59B | 0.04% | 99,679 | 31.89M |
| 288 | OCS | Oculis Holding AG | 1.59B | -1.18% | 106,929 | 1.51M |
| 289 | NUVB | Nuvation Bio Inc. | 1.57B | -0.88% | 2,622,195 | 62.90M |
| 290 | NTLA | Intellia Therapeutics, Inc. | 1.56B | 1.00% | 7,728,796 | 67.67M |
| 291 | ATAI | AtaiBeckley Inc. | 1.55B | -2.07% | 2,086,323 | 4.09M |
| 292 | IMTX | Immatics N.V. | 1.54B | 0.97% | 106,656 | 56.67M |
| 293 | GLUE | Monte Rosa Therapeutics, Inc. | 1.51B | -2.49% | 288,634 | 123.67M |
| 294 | UFPT | UFP Technologies, Inc. | 1.50B | -1.36% | 125,722 | 602.80M |
| 295 | HROW | Harrow, Inc. | 1.49B | -3.33% | 315,049 | 272.30M |
| 296 | HCSG | Healthcare Services Group, Inc. | 1.49B | -0.30% | 305,738 | 1.85B |
| 297 | DMRA | Damora Therapeutics, Inc. | 1.48B | -3.53% | 55,319 | - |
| 298 | ARDX | Ardelyx, Inc. | 1.48B | 0.50% | 777,319 | 407.32M |
| 299 | PLSE | Pulse Biosciences, Inc. | 1.48B | -4.22% | 84,054 | 350.00K |
| 300 | IMCR | Immunocore Holdings plc | 1.47B | 1.35% | 139,551 | 400.02M |
| 301 | PGNY | Progyny, Inc. | 1.46B | 1.41% | 526,849 | 1.29B |
| 302 | ATEC | Alphatec Holdings, Inc. | 1.46B | -6.90% | 1,703,137 | 764.16M |
| 303 | ATRC | AtriCure, Inc. | 1.45B | -1.06% | 292,716 | 534.53M |
| 304 | AGIO | Agios Pharmaceuticals, Inc. | 1.45B | 1.11% | 256,768 | 54.03M |
| 305 | AVAH | Aveanna Healthcare Holdings Inc. | 1.44B | -1.63% | 229,151 | 2.43B |
| 306 | NVCR | NovoCure Limited | 1.44B | -0.44% | 279,809 | 655.35M |
| 307 | BHVN | Biohaven Ltd. | 1.44B | -0.26% | 631,206 | - |
| 308 | BCAX | Bicara Therapeutics Inc. | 1.43B | -2.89% | 81,682 | - |
| 309 | MBX | MBX Biosciences, Inc. | 1.42B | -6.62% | 449,180 | - |
| 310 | WVE | Wave Life Sciences Ltd. | 1.42B | 6.27% | 2,900,749 | 71.80M |
| 311 | MAZE | Maze Therapeutics, Inc. | 1.42B | -3.08% | 419,411 | 2.50M |
| 312 | ARDT | Ardent Health, Inc. | 1.42B | -1.44% | 64,965 | 6.32B |
| 313 | PGEN | Precigen, Inc. | 1.40B | 0.13% | 838,615 | 9.68M |
| 314 | IOVA | Iovance Biotherapeutics, Inc. | 1.39B | -1.46% | 7,284,368 | 263.50M |
| 315 | VRDN | Viridian Therapeutics, Inc. | 1.38B | -0.59% | 1,934,657 | 70.85M |
| 316 | CLOV | Clover Health Investments, Corp. | 1.35B | 1.98% | 2,530,272 | 1.92B |
| 317 | ENOV | Enovis Corporation | 1.34B | -4.77% | 210,378 | 2.25B |
| 318 | BFLY | Butterfly Network, Inc. | 1.34B | -4.01% | 4,133,731 | 97.61M |
| 319 | MPLT | MapLight Therapeutics, Inc. | 1.34B | -0.82% | 97,786 | - |
| 320 | JBIO | Jade Biosciences, Inc. | 1.32B | -0.41% | 295,309 | - |
| 321 | KMTS | Kestra Medical Technologies, Ltd. | 1.30B | 0.54% | 118,985 | 83.72M |
| 322 | OLMA | Olema Pharmaceuticals, Inc. | 1.30B | -2.16% | 373,930 | - |
| 323 | CRVS | Corvus Pharmaceuticals, Inc. | 1.30B | -2.51% | 419,418 | - |
| 324 | PRCT | PROCEPT BioRobotics Corporation | 1.30B | -4.11% | 716,305 | 308.05M |
| 325 | AVBP | ArriVent BioPharma, Inc. | 1.30B | -2.93% | 249,954 | - |
| 326 | NVAX | Novavax, Inc. | 1.30B | -1.12% | 1,998,773 | 1.12B |
| 327 | STAA | STAAR Surgical Company | 1.29B | -1.99% | 272,564 | 239.44M |
| 328 | ABCL | AbCellera Biologics Inc. | 1.29B | 2.16% | 8,064,186 | 75.13M |
| 329 | TNDM | Tandem Diabetes Care, Inc. | 1.28B | -5.65% | 639,433 | 1.01B |
| 330 | SVRA | Savara Inc. | 1.28B | -2.13% | 340,801 | - |
| 331 | NNNN | Anbio Biotechnology | 1.24B | 2.17% | 20,887 | 8.65M |
| 332 | DBVT | DBV Technologies S.A. | 1.22B | 1.77% | 100,202 | 5.64M |
| 333 | MLTX | MoonLake Immunotherapeutics | 1.21B | -0.06% | 174,411 | - |
| 334 | GHRS | GH Research PLC | 1.20B | -1.25% | 106,804 | - |
| 335 | URGN | UroGen Pharma Ltd. | 1.19B | 2.73% | 220,048 | 109.79M |
| 336 | PHAR | Pharming Group N.V. | 1.18B | -3.01% | 1,053 | 376.13M |
| 337 | NEO | NeoGenomics, Inc. | 1.17B | 4.41% | 1,073,253 | 727.33M |
| 338 | CMPS | COMPASS Pathways plc | 1.15B | -4.05% | 1,984,340 | - |
| 339 | AVNS | Avanos Medical, Inc. | 1.15B | 0.06% | 683,148 | 701.20M |
| 340 | CDNA | CareDx, Inc. | 1.15B | 2.43% | 268,806 | 379.81M |
| 341 | QURE | uniQure N.V. | 1.13B | 0.56% | 499,176 | 16.10M |
| 342 | EYPT | EyePoint, Inc. | 1.12B | -1.69% | 180,048 | 31.37M |
| 343 | CNMD | CONMED Corporation | 1.11B | -2.53% | 159,901 | 1.37B |
| 344 | EVO | Evotec SE | 1.11B | -4.14% | 19,822 | 925.65M |
| 345 | INNV | InnovAge Holding Corp. | 1.11B | 0.74% | 73,157 | 915.37M |
| 346 | AZTA | Azenta, Inc. | 1.10B | -4.89% | 304,138 | 595.03M |
| 347 | IRMD | IRADIMED CORPORATION | 1.10B | -3.83% | 93,756 | 83.81M |
| 348 | USPH | U.S. Physical Therapy, Inc. | 1.09B | -1.16% | 91,554 | 773.34M |
| 349 | TDOC | Teladoc Health, Inc. | 1.09B | 3.25% | 2,932,759 | 2.53B |
| 350 | ALVO | Alvotech | 1.09B | 5.15% | 234,116 | 588.90M |
| 351 | SEPN | Septerna, Inc. | 1.08B | -4.34% | 95,502 | 45.95M |
| 352 | PNTG | The Pennant Group, Inc. | 1.07B | -0.92% | 70,468 | 947.71M |
| 353 | COLL | Collegium Pharmaceutical, Inc. | 1.06B | -0.06% | 185,488 | 780.57M |
| 354 | ZBIO | Zenas BioPharma, Inc. | 1.06B | -4.41% | 213,256 | 10.00M |
| 355 | IVA | Inventiva S.A. | 1.05B | -1.65% | 59,009 | 7.94M |
| 356 | OMER | Omeros Corporation | 1.05B | -1.29% | 1,099,252 | - |
| 357 | AKTS | Aktis Oncology, Inc. | 1.04B | -6.00% | 119,256 | 6.50M |
| 358 | XERS | Xeris Biopharma Holdings, Inc. | 1.04B | -1.39% | 498,838 | 291.85M |
| 359 | PCRX | Pacira BioSciences, Inc. | 1.03B | -0.51% | 190,349 | 726.41M |
| 360 | CRON | Cronos Group Inc. | 1.02B | -1.67% | 527,646 | 146.59M |
| 361 | BLFS | BioLife Solutions, Inc. | 1.02B | -1.68% | 129,688 | 96.21M |
| 362 | FTRE | Fortrea Holdings Inc. | 1.01B | 1.70% | 766,076 | 2.72B |
| 363 | AMPH | Amphastar Pharmaceuticals, Inc. | 974.87M | 1.11% | 107,258 | 719.89M |
| 364 | KALV | KalVista Pharmaceuticals, Inc. | 974.76M | -0.68% | 391,052 | 73.62M |
| 365 | ANNX | Annexon, Inc. | 971.79M | -1.97% | 1,229,155 | - |
| 366 | GERN | Geron Corporation | 970.96M | -0.98% | 6,777,590 | 183.88M |
| 367 | ORIC | ORIC Pharmaceuticals, Inc. | 953.40M | -6.77% | 446,589 | - |
| 368 | CERT | Certara, Inc. | 949.08M | -0.80% | 1,041,902 | 418.84M |
| 369 | OPK | OPKO Health, Inc. | 922.27M | 1.25% | 627,260 | 606.88M |
| 370 | SDGR | Schrödinger, Inc. | 916.17M | 5.71% | 961,663 | 255.87M |
| 371 | SANA | Sana Biotechnology, Inc. | 913.67M | 2.15% | 958,057 | - |
| 372 | MRVI | Maravai LifeSciences Holdings, Inc. | 912.59M | -3.53% | 375,855 | 185.74M |
| 373 | CTMX | CytomX Therapeutics, Inc. | 903.43M | -3.26% | 1,649,734 | 76.20M |
| 374 | EVMN | Evommune, Inc. | 902.98M | 0.28% | 98,629 | 13.00M |
| 375 | XNCR | Xencor, Inc. | 902.07M | -6.11% | 378,702 | 125.58M |
| 376 | LMRI | Lumexa Imaging Holdings, Inc. | 900.55M | -3.50% | 340,264 | 1.02B |
| 377 | INMD | InMode Ltd. | 898.43M | -0.91% | 188,198 | 370.50M |
| 378 | PHAT | Phathom Pharmaceuticals, Inc. | 895.97M | -2.67% | 915,310 | 175.11M |
| 379 | LBRX | LB Pharmaceuticals Inc | 894.11M | -1.98% | 61,833 | - |
| 380 | JANX | Janux Therapeutics, Inc. | 883.88M | -4.60% | 558,233 | 10.00M |
| 381 | OMDA | Omada Health, Inc. | 873.86M | 0.75% | 332,428 | 260.21M |
| 382 | DRUG | Bright Minds Biosciences Inc. | 873.45M | -0.55% | 44,224 | - |
| 383 | SLS | SELLAS Life Sciences Group, Inc. | 872.77M | -0.41% | 2,329,626 | - |
| 384 | TALK | Talkspace, Inc. | 866.29M | 0.10% | 359,656 | 228.87M |
| 385 | SSII | SS Innovations International, Inc. | 861.74M | -0.92% | 37,111 | 42.48M |
| 386 | TBPH | Theravance Biopharma, Inc. | 856.58M | -1.04% | 135,790 | 107.46M |
| 387 | MNKD | MannKind Corporation | 855.36M | 5.32% | 3,529,609 | 348.97M |
| 388 | MGTX | MeiraGTx Holdings plc | 854.30M | 1.10% | 233,996 | 81.39M |
| 389 | ANRO | Alto Neuroscience, Inc. | 844.77M | -0.70% | 63,038 | - |
| 390 | IART | Integra LifeSciences Holdings Corporation | 838.96M | 0.84% | 380,000 | 1.64B |
| 391 | BVS | Bioventus Inc. | 830.08M | -0.60% | 103,604 | 568.09M |
| 392 | AMN | AMN Healthcare Services, Inc. | 824.15M | 1.62% | 243,791 | 2.73B |
| 393 | QDEL | QuidelOrtho Corporation | 819.70M | -2.03% | 1,306,358 | 2.73B |
| 394 | CBIO | Crescent Biopharma, Inc. | 815.27M | -2.45% | 29,551 | 10.84M |
| 395 | ABUS | Arbutus Biopharma Corporation | 813.36M | -3.50% | 422,840 | 14.08M |
| 396 | GDRX | GoodRx Holdings, Inc. | 803.34M | 2.85% | 541,666 | 796.85M |
| 397 | TLRY | Tilray Brands, Inc. | 793.23M | -3.48% | 2,728,600 | 858.28M |
| 398 | DSGN | Design Therapeutics, Inc. | 790.95M | 0.12% | 83,839 | - |
| 399 | SPRY | ARS Pharmaceuticals, Inc. | 790.41M | 0.13% | 639,368 | 84.28M |
| 400 | CBLL | CeriBell, Inc. | 790.02M | -1.32% | 84,399 | 89.06M |
| 401 | KURA | Kura Oncology, Inc. | 788.66M | -2.04% | 450,698 | 67.48M |
| 402 | BIOA | BioAge Labs, Inc. | 786.51M | -1.91% | 166,709 | 9.00M |
| 403 | NUTX | Nutex Health Inc. | 781.22M | 1.19% | 96,122 | 875.26M |
| 404 | VOR | Vor Biopharma Inc. | 778.65M | 1.77% | 242,282 | - |
| 405 | CGEM | Cullinan Therapeutics, Inc. | 773.83M | -3.51% | 224,257 | - |
| 406 | SGP | SpyGlass Pharma, Inc. | 772.82M | -2.24% | 10,947 | - |
| 407 | ABSI | Absci Corporation | 761.28M | 2.58% | 4,053,715 | 2.80M |
| 408 | ALLO | Allogene Therapeutics, Inc. | 760.19M | -1.78% | 3,329,022 | 22.00K |
| 409 | RLMD | Relmada Therapeutics, Inc. | 753.10M | 2.13% | 534,171 | - |
| 410 | CSTL | Castle Biosciences, Inc. | 747.40M | -1.24% | 97,475 | 344.23M |
| 411 | SLDB | Solid Biosciences Inc. | 729.10M | -1.20% | 348,255 | - |
| 412 | TENX | Tenax Therapeutics, Inc. | 721.31M | -5.10% | 684,723 | - |
| 413 | TRAX | First Tracks Biotherapeutics, Inc. | 708.88M | 12.71% | 285,783 | - |
| 414 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 708.69M | 0.74% | 352,317 | - |
| 415 | LXRX | Lexicon Pharmaceuticals, Inc. | 707.55M | -1.18% | 637,809 | 49.80M |
| 416 | GYRE | Gyre Therapeutics, Inc. | 699.47M | 0.39% | 28,538 | 116.59M |
| 417 | EHAB | Enhabit, Inc. | 697.70M | 0.11% | 197,814 | 1.06B |
| 418 | BWAY | BrainsWay Ltd. | 663.54M | -3.21% | 75,514 | 52.23M |
| 419 | IRWD | Ironwood Pharmaceuticals, Inc. | 658.76M | - | 464,205 | 296.15M |
| 420 | FBRX | Forte Biosciences, Inc. | 657.24M | 0.19% | 176,588 | - |
| 421 | ARVN | Arvinas, Inc. | 655.60M | -0.39% | 165,472 | 262.60M |
| 422 | PRME | Prime Medicine, Inc. | 655.19M | 0.82% | 1,043,859 | 4.63M |
| 423 | DRTS | Alpha Tau Medical Ltd. | 650.39M | -6.57% | 376,421 | - |
| 424 | ETON | Eton Pharmaceuticals, Inc. | 647.46M | 1.19% | 101,223 | 79.95M |
| 425 | HSTM | HealthStream, Inc. | 634.46M | 1.03% | 65,431 | 304.06M |
| 426 | PRTA | Prothena Corporation plc | 601.31M | 3.52% | 162,312 | 9.68M |
| 427 | CRMD | CorMedix Inc. | 596.05M | -2.81% | 657,694 | 311.71M |
| 428 | CTKB | Cytek Biosciences, Inc. | 595.19M | 3.81% | 226,747 | 201.49M |
| 429 | STRO | Sutro Biopharma, Inc. | 592.28M | 6.43% | 127,597 | 102.48M |
| 430 | ACRS | Aclaris Therapeutics, Inc. | 592.12M | -3.40% | 927,484 | 7.83M |
| 431 | ZVRA | Zevra Therapeutics, Inc. | 584.65M | 0.82% | 280,875 | 106.47M |
| 432 | PHR | Phreesia, Inc. | 581.50M | -0.52% | 411,364 | 480.59M |
| 433 | NPCE | NeuroPace, Inc. | 581.23M | -0.75% | 88,182 | 99.99M |
| 434 | PSNL | Personalis, Inc. | 575.73M | -7.72% | 1,217,223 | 69.65M |
| 435 | STTK | Shattuck Labs, Inc. | 571.78M | -2.01% | 186,706 | 1.00M |
| 436 | RIGL | Rigel Pharmaceuticals, Inc. | 567.71M | 0.69% | 127,856 | 294.28M |
| 437 | OCGN | Ocugen, Inc. | 563.63M | -2.06% | 3,075,292 | 4.41M |
| 438 | PROK | ProKidney Corp. | 558.63M | -0.54% | 163,543 | 893.00K |
| 439 | SIBN | SI-BONE, Inc. | 551.28M | -5.25% | 205,590 | 200.93M |
| 440 | EMBC | Embecta Corp. | 544.82M | -0.43% | 331,168 | 1.08B |
| 441 | ALT | Altimmune, Inc. | 535.99M | -1.43% | 2,306,074 | 41.00K |
| 442 | AVR | Anteris Technologies Global Corp. | 527.94M | 0.35% | 945,923 | 1.91M |
| 443 | TCMD | Tactile Systems Technology, Inc. | 526.22M | -4.58% | 152,180 | 329.52M |
| 444 | KYTX | Kyverna Therapeutics, Inc. | 526.01M | -3.34% | 394,909 | - |
| 445 | TECX | Tectonic Therapeutic, Inc. | 517.58M | -4.12% | 63,619 | - |
| 446 | AGMB | AgomAb Therapeutics NV | 511.74M | -7.24% | 75,671 | - |
| 447 | UPB | Upstream Bio, Inc. | 507.74M | 0.43% | 207,272 | 2.85M |
| 448 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 449 | LYEL | Lyell Immunopharma, Inc. | 503.89M | -4.51% | 35,526 | 36.00K |
| 450 | ZURA | Zura Bio Limited | 502.87M | -2.03% | 168,748 | - |
| 451 | MDXG | MiMedx Group, Inc. | 499.18M | 0.60% | 531,659 | 418.63M |
| 452 | FULC | Fulcrum Therapeutics, Inc. | 497.75M | -3.24% | 351,378 | 80.00M |
| 453 | VREX | Varex Imaging Corporation | 497.58M | -6.61% | 87,814 | 854.40M |
| 454 | AQST | Aquestive Therapeutics, Inc. | 497.33M | -0.61% | 380,555 | 44.55M |
| 455 | XOMA | XOMA Royalty Corporation | 493.43M | -1.33% | 322,867 | 52.15M |
| 456 | ESPR | Esperion Therapeutics, Inc. | 491.64M | - | 2,564,640 | 403.14M |
| 457 | VALN | Valneva SE | 485.14M | 0.73% | 26,163 | 205.07M |
| 458 | OFIX | Orthofix Medical Inc. | 484.94M | -1.95% | 117,728 | 822.31M |
| 459 | FDMT | 4D Molecular Therapeutics, Inc. | 482.44M | - | 177,236 | 85.21M |
| 460 | ADCT | ADC Therapeutics SA | 479.50M | 0.27% | 347,346 | 81.36M |
| 461 | VSTM | Verastem, Inc. | 476.99M | -1.99% | 1,056,588 | 30.91M |
| 462 | KMDA | Kamada Ltd. | 474.78M | -1.22% | 16,080 | 180.46M |
| 463 | IMMX | Immix Biopharma, Inc. | 467.57M | -7.45% | 340,162 | - |
| 464 | PACB | Pacific Biosciences of California, Inc. | 466.59M | -2.83% | 2,105,026 | 160.01M |
| 465 | OVID | Ovid Therapeutics Inc. | 466.34M | 0.19% | 877,368 | 7.25M |
| 466 | CATX | Perspective Therapeutics, Inc. | 465.19M | -4.45% | 600,118 | 884.00K |
| 467 | AGL | agilon health, inc. | 464.99M | 10.66% | 190,752 | 5.93B |
| 468 | ENGN | enGene Therapeutics Inc. | 464.57M | -3.68% | 1,557,073 | - |
| 469 | MYGN | Myriad Genetics, Inc. | 462.30M | 1.35% | 317,424 | 824.50M |
| 470 | ANGO | AngioDynamics, Inc. | 459.75M | -0.54% | 111,862 | 313.73M |
| 471 | CGC | Canopy Growth Corporation | 458.59M | -2.08% | 6,742,703 | 203.04M |
| 472 | TRDA | Entrada Therapeutics, Inc. | 458.46M | -1.74% | 66,329 | 25.42M |
| 473 | CTNM | Contineum Therapeutics, Inc. | 457.74M | -5.47% | 54,310 | - |
| 474 | ANL | Adlai Nortye Ltd. | 455.20M | -14.11% | 861,814 | 5.00M |
| 475 | DNA | Ginkgo Bioworks Holdings, Inc. | 454.02M | -0.26% | 211,242 | 170.16M |
| 476 | BBNX | Beta Bionics, Inc. | 451.41M | -4.88% | 279,254 | 110.24M |
| 477 | LRMR | Larimar Therapeutics, Inc. | 450.85M | -2.25% | 832,035 | - |
| 478 | CADL | Candel Therapeutics, Inc. | 448.64M | -2.62% | 358,779 | - |
| 479 | EIKN | Eikon Therapeutics, Inc. | 448.54M | -5.21% | 153,831 | - |
| 480 | AVIR | Atea Pharmaceuticals, Inc. | 446.96M | 4.66% | 131,300 | - |
| 481 | EPRX | Eupraxia Pharmaceuticals Inc. | 445.74M | -1.46% | 141,377 | - |
| 482 | RGNX | REGENXBIO Inc. | 444.94M | - | 215,438 | 170.44M |
| 483 | AURA | Aura Biosciences, Inc. | 441.69M | -1.15% | 47,926 | - |
| 484 | FLGT | Fulgent Genetics, Inc. | 439.30M | -2.37% | 189,866 | 322.67M |
| 485 | CLYM | Climb Bio, Inc. | 436.60M | -3.79% | 2,179,893 | - |
| 486 | SRTA | Strata Critical Medical, Inc. | 435.26M | 1.72% | 296,663 | 197.14M |
| 487 | NGNE | Neurogene Inc. | 431.62M | 2.18% | 69,208 | 925.00K |
| 488 | ASMB | Assembly Biosciences, Inc. | 428.45M | -1.85% | 26,485 | 72.30M |
| 489 | PRTC | PureTech Health plc | 427.41M | 2.02% | 12,443 | 6.39M |
| 490 | PRLD | Prelude Therapeutics Incorporated | 425.34M | -6.42% | 235,808 | 12.14M |
| 491 | BNTC | Benitec Biopharma Inc. | 423.05M | -2.06% | 36,668 | - |
| 492 | LXEO | Lexeo Therapeutics, Inc. | 423.04M | 1.51% | 168,135 | - |
| 493 | EBS | Emergent BioSolutions Inc. | 420.90M | 1.49% | 187,379 | 742.90M |
| 494 | EVH | Evolent Health, Inc. | 401.90M | 3.75% | 916,113 | 1.88B |
| 495 | VNDA | Vanda Pharmaceuticals Inc. | 400.75M | -0.15% | 552,362 | 216.11M |
| 496 | CTEV | Claritev Corporation | 398.92M | -0.50% | 35,095 | 965.41M |
| 497 | IVVD | Invivyd, Inc. | 397.34M | -3.77% | 629,332 | 53.43M |
| 498 | IPSC | Century Therapeutics, Inc. | 397.03M | -2.00% | 226,040 | 109.16M |
| 499 | NMRA | Neumora Therapeutics, Inc. | 396.43M | -2.25% | 414,867 | - |
| 500 | KIDS | OrthoPediatrics Corp. | 395.82M | -2.59% | 132,836 | 236.35M |